Immune response to pneumococcal conjugate and polysaccharide vaccines in otitis-prone and otitis-free children

被引:36
作者
Barnett, ED
Pelton, SI
Cabral, HJ
Eavey, RD
Allen, C
Cunningham, MJ
McNamara, ER
Klein, JO
机构
[1] Boston Med Ctr, Maxwell Finland Lab Infect Dis, Boston, MA 02118 USA
[2] Boston Univ, Sch Publ Hlth, Data Coordinating Ctr, Boston, MA USA
[3] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Dept Otolaryngol, Boston, MA USA
[4] Childrens Hlth Care, Arlington, MA USA
关键词
D O I
10.1086/520151
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We compared responses to pneumococcal conjugate and polysaccharide vaccines in 48 otitis-free and 64 otitis-prone children. Pre- and postimmunization concentrations of antibodies to pneumococcal serotypes 6B, 14, 19F, and 23F were measured by enzyme-linked immunosorbent assay. Postimmunization mean concentrations of antibodies to all four serotypes were significantly higher for children receiving conjugate vaccine than for those receiving polysaccharide vaccine; the difference in responses was primarily due to a better response to conjugate vaccine in the otitis-prone group, Significantly higher postimmunization concentrations of antibodies to all four serotypes and to one of the four serotypes were found in otitis-prone children and otitis-free children who received conjugate vaccine, respectively, Pneumococcal conjugate vaccine has the potential to reduce the incidence of disease due to vaccine serotypes, even among children with recurrent otitis media.
引用
收藏
页码:191 / 192
页数:2
相关论文
共 3 条